Duquesne Family Office 13F, Q3 2024
Stanley Druckenmiller · quarter ending 30 September 2024 · filed 14 November 2024 · SEC CIK 1536411
Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 3 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.
Largest positions, Q3 2024
The 25 largest of 72 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2024 filing.
| Company | Ticker | Value | % of book | vs Q2 2024 |
|---|---|---|---|---|
| Natera Inc | NTRA | $452.81M | 15.9% | +81% shares |
| Coupang Inc | CPNG | $287.14M | 10.1% | +7% shares |
| Coherent Corp | COHR | $264.82M | 9.3% | -17% shares |
| Woodward Inc | WWD | $181.41M | 6.4% | +11% shares |
| Seagate Technology Hldngs Pl | $179.67M | 6.3% | -7% shares | |
| Philip Morris Intl Inc | PM | $137.75M | 4.8% | +28% shares |
| Spdr Ser Tr | KRE | $116.22M | 4.1% | new |
| Mercadolibre Inc | MELI | $98.72M | 3.5% | +32% shares |
| Freeport-Mcmoran Inc | FCX | $68.74M | 2.4% | +19% shares |
| Flutter Entmt Plc | $61.82M | 2.2% | -22% shares | |
| Kinder Morgan Inc Del | KMI | $57.70M | 2.0% | -61% shares |
| Teck Resources Ltd | TECK | $53.13M | 1.9% | -30% shares |
| Vistra Corp | VST | $46.39M | 1.6% | -85% shares |
| Broadcom Inc | AVGO | $41.40M | 1.4% | new |
| Discover Finl Svcs | $39.96M | 1.4% | +70% shares | |
| Ascendis Pharma A/S | $39.57M | 1.4% | new | |
| Mid-Amer Apt Cmntys Inc | MAA | $37.93M | 1.3% | -63% shares |
| Camden Ppty Tr | CPT | $35.94M | 1.3% | -50% shares |
| Daktronics Inc | DAKT | $33.16M | 1.2% | +3% shares |
| Wabtec | WAB | $32.66M | 1.1% | +19% shares |
| Nvent Electric Plc | $31.69M | 1.1% | new | |
| Banco Macro Sa | BMA | $26.93M | 0.9% | +55% shares |
| Teva Pharmaceutical Inds Ltd | TEVA | $25.73M | 0.9% | new |
| Barclays Plc | BCS | $24.39M | 0.8% | -3% shares |
| United States Stl Corp | $23.43M | 0.8% | new |
What changed since Q2 2024
Against the Q2 2024 filing, Duquesne Family Office opened 31 new positions, added to 11, trimmed 19, left 11 unchanged and exited 22. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
- KRE$116.22M
- AVGO$41.40M
- Ascendis Pharma A/S$39.57M
- Nvent Electric Plc$31.69M
- TEVA$25.73M
- United States Stl Corp$23.43M
- CNM$21.10M
- C$20.50M
and 23 more
Exited
- OPCHwas $51.85M
- NVDAwas $26.45M
- MSGEwas $23.76M
- NWSAwas $18.85M
- Arista Networks Incwas $18.32M
- NWSwas $18.05M
- BAHwas $12.90M
- IQVwas $12.76M
and 14 more
Other quarters
Source: SEC Form 13F-HR, accession 0001536411-24-000009, filed by Duquesne Family Office LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.